Development of a Vaccine Against Inflammatory Diseases

Impact of Gut Bacteria on Health

The bacteria residing in the human gut significantly influence overall health and well-being. Pathogenic bacteria can induce inflammation in the intestinal lining, potentially leading to several health issues, including inflammatory bowel diseases (IBD) and Crohn’s disease. Additionally, these bacteria are linked to metabolic syndrome, which encompasses a range of changes in a healthy individual that heighten the risk of chronic illnesses such as heart disease and type 2 diabetes. Common symptoms of metabolic syndrome include increased abdominal fat, elevated blood pressure, high triglyceride levels, low levels of good cholesterol (HDL), and insulin resistance.

Research Insights on Inflammation and Metabolic Diseases

While dietary changes and physical activity are frequently recommended to address metabolic disease risks, recent studies have highlighted the role of gut bacteria in causing colon inflammation, thereby raising the likelihood of both metabolic and inflammatory bowel diseases.

Research Conducted in Georgia

Researchers in Georgia aimed to explore whether enhancing a mouse’s ability to combat pathogenic bacteria could alleviate bowel inflammation. They focused on a protein common in many pathogenic bacteria, known as flagellin. This protein is integral to the flagella, the hair-like structures that enable bacteria to move.

Vaccine Mechanism and Effects

By generating antibodies against flagellin, the researchers effectively created a vaccine-like response against the bacteria responsible for inflammation. After administering flagellin protein into the abdomens of the mice, there was a notable increase in anti-flagellin antibodies, enhancing the mice’s capacity to fend off pathogenic bacteria. Microscopic examinations revealed that the intestinal lining of the vaccinated mice maintained a greater distance from harmful bacteria, protecting the underlying cell layers and mucous membranes.

Observations Post-Vaccination

Further findings indicated a shift in the composition of intestinal bacteria in vaccinated mice, who exhibited lower levels of harmful bacteria in their feces compared to the control group that did not receive flagellin. Additionally, mice on a diet designed to induce obesity gained less weight after flagellin injections than those receiving the control liquid, suggesting that managing inflammation-causing bacteria could mitigate metabolic disease risks.

Benefits for Genetically Modified Mice

The research also involved genetically modified mice predisposed to inflammatory bowel diseases. These mice demonstrated an enhanced ability to combat inflammation-causing bacteria, resulting in a reduction of bowel disease symptoms.

Potential Implications for Human Health

The findings present a promising avenue for developing future therapies targeting prevalent diseases in the adult population. With over 40% of adults aged 65 and older exhibiting risk factors for metabolic syndrome, and heart disease and diabetes contributing to over a third of deaths in Canada, a vaccine against inflammatory diseases could lower healthcare costs and reduce mortality rates linked to metabolic diseases. If successfully adapted for human use, a similar vaccine could yield significant medical advancements for chronic diseases, particularly benefiting elderly individuals and those suffering from various inflammatory bowel conditions.

Conclusion

The research conducted by Nancy Lemieux and colleagues opens the door for innovative treatments that could enhance the quality of life for many, suggesting a healthier and more promising future through the use of flagellin-based therapies.

References

Tran, H.Q., Ley, R.E., Gewirtz, A.T. et al. Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chronic inflammatory diseases. Nat Commun 10, 5650 (2019).
Researchers develop approach to alter intestinal microbiota, vaccinate against inflammatory diseases. (2019). Retrieved 11 December 2019, from https://www.eurekalert.org/pub_releases/2019-12/gsu-rda120919.php
Metabolic Syndrome: A health crisis hiding in plain sight. (2019). Retrieved 11 December 2019, from https://www.metabolicsyndromecanada.ca/about-metabolic-syndrome
Image by HeungSoon from Pixabay